RO
Ross Osborn Cantor Fitzgerald Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Organogenesis Holdings
ORGO
$634M
| $5 | $9 |
80%
upside
| Overweight | 1 month ago |
|
2
LeMaitre Vascular
LMAT
$2.21B
| $97.49 | $95 |
3%
downside
| Neutral | 1 month ago |
|
3
SI-BONE Inc
SIBN
$703M
| $16.29 | $25 |
53%
upside
| Overweight | 1 month ago |
|
4
MiMedx Group
MDXG
$1.06B
| $7.14 | $12 |
68%
upside
| Overweight | 1 month ago |
|
5
Bioventus
BVS
$481M
| $7.19 | $12 |
67%
upside
| Overweight | 2 months ago |
|
6
Neuropace
NPCE
$322M
| $9.73 | $17 |
75%
upside
| Overweight | 3 months ago |
|
7
Sanara MedTech
SMTI
$299M
| $33.57 | $46 |
37%
upside
| Overweight | 5 months ago |
|
8
Axogen
AXGN
$735M
| $15.98 | $24 |
50%
upside
| Overweight | 6 months ago |
|
9
Cerus
CERS
$255M
| $1.33 | $4 |
201%
upside
| Overweight | 6 months ago |
|
10
Pacific Biosciences
PACB
$381M
| $1.27 | $3.50 |
176%
upside
| Overweight | 1 year ago |
|